Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Carcieri

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Recenti Progressi in Medicina|November 17, 2024
Silvia Scalpello, Chiara Carcieri, Agnese Bosio, et al.
Recenti Progressi in Medicina|December 17, 2024
Agnese Bosio, Chiara Carcieri, Sixberth Bugeraha, et al.
Pharmacogenetics and Genomics|May 4, 2016
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Pharmacogenomics|April 29, 2017
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphismsAntonio D'Avolio, Chiara Carcieri, Jessica Cusato, et al.
The Journal of Pharmacy and Pharmacology|October 24, 2017
Cannabinoids concentration variability in cannabis olive oil galenic preparationsChiara Carcieri, Cristina Tomasello, Marco Simiele, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 22, 2015
A LC-MS method to quantify tenofovir urinary concentrations in treated patientsMarco Simiele, Chiara Carcieri, Amedeo De Nicolò, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2017
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasmaMarco Simiele, Alessandra Ariaudo, Amedeo De Nicolò, et al.
Infection|November 18, 2016
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitorsLucio Boglione, Simone Mornese Pinna, Chiara Simona Cardellino, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2016
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasmaAlessandra Ariaudo, Fabio Favata, Amedeo De Nicolò, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Recenti Progressi in Medicina|November 17, 2024
Silvia Scalpello, Chiara Carcieri, Agnese Bosio, et al.
Recenti Progressi in Medicina|December 17, 2024
Agnese Bosio, Chiara Carcieri, Sixberth Bugeraha, et al.
Pharmacogenetics and Genomics|May 4, 2016
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
Pharmacogenomics|April 29, 2017
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphismsAntonio D'Avolio, Chiara Carcieri, Jessica Cusato, et al.
The Journal of Pharmacy and Pharmacology|October 24, 2017
Cannabinoids concentration variability in cannabis olive oil galenic preparationsChiara Carcieri, Cristina Tomasello, Marco Simiele, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 22, 2015
A LC-MS method to quantify tenofovir urinary concentrations in treated patientsMarco Simiele, Chiara Carcieri, Amedeo De Nicolò, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2017
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasmaMarco Simiele, Alessandra Ariaudo, Amedeo De Nicolò, et al.
Infection|November 18, 2016
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitorsLucio Boglione, Simone Mornese Pinna, Chiara Simona Cardellino, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2016
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasmaAlessandra Ariaudo, Fabio Favata, Amedeo De Nicolò, et al.
Pageof 3